245 related articles for article (PubMed ID: 21095568)
1. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.
Hu J; Liu J; Corey DR
Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568
[TBL] [Abstract][Full Text] [Related]
2. Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs.
Hu J; Liu J; Yu D; Aiba Y; Lee S; Pendergraff H; Boubaker J; Artates JW; Lagier-Tourenne C; Lima WF; Swayze EE; Prakash TP; Corey DR
Nucleic Acid Ther; 2014 Jun; 24(3):199-209. PubMed ID: 24694346
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway.
Hu J; Liu J; Yu D; Chu Y; Corey DR
Nucleic Acids Res; 2012 Dec; 40(22):11270-80. PubMed ID: 23042244
[TBL] [Abstract][Full Text] [Related]
4. Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions.
Aiba Y; Hu J; Liu J; Xiang Q; Martinez C; Corey DR
Biochemistry; 2013 Dec; 52(51):9329-38. PubMed ID: 24266403
[TBL] [Abstract][Full Text] [Related]
5. Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA.
Hu J; Matsui M; Corey DR
Ann N Y Acad Sci; 2009 Sep; 1175():24-31. PubMed ID: 19796074
[TBL] [Abstract][Full Text] [Related]
6. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.
Boudreau RL; McBride JL; Martins I; Shen S; Xing Y; Carter BJ; Davidson BL
Mol Ther; 2009 Jun; 17(6):1053-63. PubMed ID: 19240687
[TBL] [Abstract][Full Text] [Related]
7. RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression.
Liu J; Pendergraff H; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Hu J; Corey DR
Nucleic Acids Res; 2013 Oct; 41(18):8788-801. PubMed ID: 23887934
[TBL] [Abstract][Full Text] [Related]
8. Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression.
Yu D; Pendergraff H; Liu J; Kordasiewicz HB; Cleveland DW; Swayze EE; Lima WF; Crooke ST; Prakash TP; Corey DR
Cell; 2012 Aug; 150(5):895-908. PubMed ID: 22939619
[TBL] [Abstract][Full Text] [Related]
9. Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs.
Hu J; Liu J; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Swayze EE; Lima WF; Prakash TP; Xiang Q; Martinez C; Corey DR
Biochemistry; 2014 Jul; 53(28):4510-8. PubMed ID: 24981774
[TBL] [Abstract][Full Text] [Related]
10. Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts.
van Bilsen PH; Jaspers L; Lombardi MS; Odekerken JC; Burright EN; Kaemmerer WF
Hum Gene Ther; 2008 Jul; 19(7):710-9. PubMed ID: 18549309
[TBL] [Abstract][Full Text] [Related]
11. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
Gagnon KT; Pendergraff HM; Deleavey GF; Swayze EE; Potier P; Randolph J; Roesch EB; Chattopadhyaya J; Damha MJ; Bennett CF; Montaillier C; Lemaitre M; Corey DR
Biochemistry; 2010 Nov; 49(47):10166-78. PubMed ID: 21028906
[TBL] [Abstract][Full Text] [Related]
12. Sustained effects of nonallele-specific Huntingtin silencing.
Drouet V; Perrin V; Hassig R; Dufour N; Auregan G; Alves S; Bonvento G; Brouillet E; Luthi-Carter R; Hantraye P; Déglon N
Ann Neurol; 2009 Mar; 65(3):276-85. PubMed ID: 19334076
[TBL] [Abstract][Full Text] [Related]
13. Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.
Fiszer A; Olejniczak M; Galka-Marciniak P; Mykowska A; Krzyzosiak WJ
Nucleic Acids Res; 2013 Dec; 41(22):10426-37. PubMed ID: 24038471
[TBL] [Abstract][Full Text] [Related]
14. AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's disease.
Miniarikova J; Zimmer V; Martier R; Brouwers CC; Pythoud C; Richetin K; Rey M; Lubelski J; Evers MM; van Deventer SJ; Petry H; Déglon N; Konstantinova P
Gene Ther; 2017 Oct; 24(10):630-639. PubMed ID: 28771234
[TBL] [Abstract][Full Text] [Related]
15. Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease.
McBride JL; Pitzer MR; Boudreau RL; Dufour B; Hobbs T; Ojeda SR; Davidson BL
Mol Ther; 2011 Dec; 19(12):2152-62. PubMed ID: 22031240
[TBL] [Abstract][Full Text] [Related]
16. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.
Harper SQ; Staber PD; He X; Eliason SL; Martins IH; Mao Q; Yang L; Kotin RM; Paulson HL; Davidson BL
Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5820-5. PubMed ID: 15811941
[TBL] [Abstract][Full Text] [Related]
17. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo.
Huang B; Schiefer J; Sass C; Landwehrmeyer GB; Kosinski CM; Kochanek S
Hum Gene Ther; 2007 Apr; 18(4):303-11. PubMed ID: 17472569
[TBL] [Abstract][Full Text] [Related]
18. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
19. Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.
Hu J; Matsui M; Gagnon KT; Schwartz JC; Gabillet S; Arar K; Wu J; Bezprozvanny I; Corey DR
Nat Biotechnol; 2009 May; 27(5):478-84. PubMed ID: 19412185
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.
Fiszer A; Olejniczak M; Switonski PM; Wroblewska JP; Wisniewska-Kruk J; Mykowska A; Krzyzosiak WJ
BMC Mol Biol; 2012 Mar; 13():6. PubMed ID: 22397573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
